Assistant Professor, Pathology & Laboratory Medicine, Associate Director, Pathology Residency Program, Emory University
BIOGRAPHY
Speaker
Event Date & Time
DATE: September 29, 2016
TIME: 10:00am PT, 1:00pm ET
TIME: 10:00am PT, 1:00pm ET
Abstract
One of the challenges with personalized medicine lies in the identification of robust, clinically relevant biomarkers. Traditional approaches to biomarker discovery either focus on only a subset of the potential targets, or have insufficient resolution to discriminate small or rare changes that may carry biological significance.
Recent technological advancement has made high-resolution whole-genome and whole-transcriptome profiling a reality. Translational researchers can now simultaneously search broadly and deeply to efficiently identify potential biomarkers from samples in a matter of days, without requiring resource-intensive bioinformatics support.
During the webinar, Dr. Stewart Neill will:
- Discuss the importance of copy number variation and copy-neutral loss of heterozygosity in the modern classification and subclassification of CNS neoplasia
- Demonstrate how advancements in technologies with greater sensitivity can detect important cytogenomic events that are driving the discovery of novel biomarkers
- Illustrate the use of microarray-based technologies in a clinical research setting through a case study approach
- Answer your questions live during the broadcast!
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...